Aditxt, Inc. Other Selling, General and Administrative Expense
Aditxt, Inc. (ADTX) reported Other Selling, General and Administrative Expense of $504.70 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2023-04-17
- Aditxt, Inc. other selling, general and administrative expense for the quarter ending 2022-12-31 was $399.65K.
- Aditxt, Inc. other selling, general and administrative expense for the quarter ending 2022-09-30 was $52.52K.
- Aditxt, Inc. other selling, general and administrative expense for the quarter ending 2021-12-31 was -$317.23K.
- Aditxt, Inc. other selling, general and administrative expense for fiscal 2022 was $504.70K, a 110.65% increase from fiscal 2021.
- Aditxt, Inc. other selling, general and administrative expense for fiscal 2021 was $239.59K.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 6 month | Other Selling, General and Administrative Expense 9 month | Other Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $399.65K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $452.18K derived: sum of 2 quarters · filed 2023-04-17 | $504.70K 10-K · filed 2023-04-17 | |
| 2022-09-30 | $52.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $105.05K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $52.52K 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | -$317.23K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $239.59K 10-K · filed 2023-04-17 | ||
| 2021-09-30 | $556.82K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |